Stocks Health care PMN
NASDAQ · Health careProMIS Neurosciences Inc. (PMN)
It posted a net loss of $42.2M. At June 30, 2026 it held $53.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What ProMIS Neurosciences Inc. does
ProMIS Neurosciences Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PMN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$39.7M | -$22.61 | n/a |
| 2024 | n/a | $2.8M | $2.63 | n/a |
| 2023 | n/a | -$13.2M | -$25.58 | n/a |
| 2022 | n/a | -$18.1M | -$57.62 | -$17M |
| 2022 | n/a | -$9.8M | -$40.41 | -$9.3M |
Latest SEC filings
What ProMIS Neurosciences Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- July 28, 2026
- May 29, 2026
- May 20, 2026
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
Questions about PMN
What does ProMIS Neurosciences Inc. do?
ProMIS Neurosciences Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PMN.
Is ProMIS Neurosciences Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $42.2M.
When did ProMIS Neurosciences Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from August 14, 2026.
Similar companies
Follow PMN
Get an email when ProMIS Neurosciences Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PMN: get an email when it filesWhere the numbers come from
Financial figures are the values ProMIS Neurosciences Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.